Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in 
pituitary adenomas: pathological and clinical implications

Jaffrain-Rea, M. L.; Angelini, M.; Gargano, D.; Tichomirowa, M. A.; Daly, A. F.; Vanbellinghen, J. F.; D'Innocenzo, E.; Barlier, A.; Giangaspero, F.; Esposito, V.; Ventura, L.; Arcella, A.; Theodoropoulou, M.; Naves, L. A.; Fajardo, C.; Zacharieva, S.; Rohmer, V.; Brue, T.; Gulino, A.; Cantore, G.; Alesse, E.; Beckers, A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

MPS-Authors

/persons/resource/persons80552

Tichomirowa, M. A.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80549

Theodoropoulou, M.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Jaffrain-Rea, M. L., Angelini, M., Gargano, D., Tichomirowa, M. A., Daly, A. F., Vanbellinghen, J. F., et al. (2009). Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocrine-Related Cancer, 16(3), 1029-1043.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-9247-A

Abstract

There is no abstract available